Acute Kidney Injury Associated With Remdesivir: A Comprehensive Pharmacovigilance Analysis of COVID-19 Reports in FAERS
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Acute Kidney Injury Associated With Remdesivir: A Comprehensive Pharmacovigilance Analysis of COVID-19 Reports in FAERS
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-03-30
DOI
10.3389/fphar.2022.692828
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mortality Benefit of Remdesivir in COVID-19: A Systematic Review and Meta-Analysis
- (2021) Vikas Bansal et al. Frontiers in Medicine
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- COVID‐19 and Older People in Asia: AWGS Calls to Actions
- (2020) Wee‐Shiong Lim et al. Geriatrics & Gerontology International
- COVID ‐19 and Older Adults: What We Know
- (2020) Zainab Shahid et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Acute kidney injury in patients hospitalized with COVID-19
- (2020) Jamie S. Hirsch et al. KIDNEY INTERNATIONAL
- Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China
- (2020) Hua Su et al. KIDNEY INTERNATIONAL
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19
- (2020) Meagan L. Adamsick et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients
- (2020) Michael J. Joyner et al. MAYO CLINIC PROCEEDINGS
- Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre‐COVID‐19 reports
- (2020) Adam Goldman et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- AKI in Hospitalized Patients with COVID-19
- (2020) Lili Chan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Acute Kidney Injury in COVID-19: The Chinese Experience
- (2020) Xizi Zheng et al. SEMINARS IN NEPHROLOGY
- Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database
- (2020) Alexandre O. Gérard et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Propensity Score Methods for Bias Reduction in Observational Studies of Treatment Effect
- (2018) Sindhu R. Johnson et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies
- (2017) Xiaoxin I. Yao et al. JNCI-Journal of the National Cancer Institute
- Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies
- (2017) Xiaoxin I. Yao et al. JNCI-Journal of the National Cancer Institute
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now